Konferenzschrift | Kongress
Human tumour xenografts in anticancer drug development
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540186380
3540186387
9780387186382
0387186387
- Maße
-
29 cm
- Umfang
-
XIV, 143 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Schlagwort
-
Krebs
Heterotransplantation
Chemotherapie
Tiermodell
Krebs
Geschwulst
Zytostatika
Krebs
Tumor
Cytostatikum
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin, Heidelberg, New York, London, Paris, Tokyo
- (wer)
-
Springer
- (wann)
-
1988
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:13 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Winograd, Benjamin
- European School of Oncology
- Seminar on Human Tumour Xenografts (1986 : Mailand)
- Springer
Entstanden
- 1988
Ähnliche Objekte (12)
New anticancer drugs
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
A mechanistic assessment of novel anticancer drugs targeting the metastatic cascade and tumour vascularisation.
Neurological adverse reactions to anticancer drugs
Molecular aspects of anti-cancer drug action
Evaluation of computational and biophysical screening methods for the development of anticancer drugs
Machine learning-based anti-cancer drug treatment optimization
Supramolecular metallocages as potential delivery systems for anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Activation of apoptosis pathways by different classes of anticancer drugs
Neocarzinostatin : the past, present, and future of an anticancer drug
New anticancer drugs
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
A mechanistic assessment of novel anticancer drugs targeting the metastatic cascade and tumour vascularisation.
Neurological adverse reactions to anticancer drugs
Molecular aspects of anti-cancer drug action
Evaluation of computational and biophysical screening methods for the development of anticancer drugs
Machine learning-based anti-cancer drug treatment optimization
Supramolecular metallocages as potential delivery systems for anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Activation of apoptosis pathways by different classes of anticancer drugs
Neocarzinostatin : the past, present, and future of an anticancer drug
New anticancer drugs
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
A mechanistic assessment of novel anticancer drugs targeting the metastatic cascade and tumour vascularisation.
Neurological adverse reactions to anticancer drugs
Molecular aspects of anti-cancer drug action
Evaluation of computational and biophysical screening methods for the development of anticancer drugs
Machine learning-based anti-cancer drug treatment optimization
Supramolecular metallocages as potential delivery systems for anticancer drugs
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Activation of apoptosis pathways by different classes of anticancer drugs